EMA press briefing 5 May 2022

EMA press briefing 5 May 2022       Human medicines European public assessment report (EPAR): Evusheld, tixagevimab,cilgavimab, COVID-19 virus infection, Date of authorisation: 25/03/2022, Status: Authorised Human medicines European public assessment report (EPAR): Evusheld, tixagevimab,cilgavimab, COVID-19 virus infection, Date of authorisation: 25/03/2022, Status: Authorised       Indicator on Life expectancy (I) (ECHI 10) updated with most recent Eurostat statistics Indicator on Life expectancy (I) (ECHI 10) updated with most recent Eurostat statistics

Actueel zorgnieuws in jouw mailbox ontvangen?

Direct het hele artikel lezen? Meld je aan voor de nieuwsbrief.